PA8601501A1 - PROCESS - Google Patents

PROCESS

Info

Publication number
PA8601501A1
PA8601501A1 PA20048601501A PA8601501A PA8601501A1 PA 8601501 A1 PA8601501 A1 PA 8601501A1 PA 20048601501 A PA20048601501 A PA 20048601501A PA 8601501 A PA8601501 A PA 8601501A PA 8601501 A1 PA8601501 A1 PA 8601501A1
Authority
PA
Panama
Prior art keywords
amlodipine
pulified
monohidrate
mesilate
anhydro
Prior art date
Application number
PA20048601501A
Other languages
Spanish (es)
Inventor
Narayanrao Kankan Rajendra
Ramachandra Rao Dharmaraj
Pathi L Srinivas
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0309471A external-priority patent/GB0309471D0/en
Priority claimed from GB0314617A external-priority patent/GB0314617D0/en
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of PA8601501A1 publication Critical patent/PA8601501A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/44221,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MONOHIDRATO DE MESILATO DE AMLODIPINA ES PREPARADO YA SEA A PARTIR DE MESILATO DE AMLODIPINA ANHIDRO, O EN LA PRESENCIA DE UN MEDIO SOLVENTE DE AGUA INMISCIBLE A PARTIR DE AMLODIPINA PURIFICADA Y ACIDO SULFONICO DE METANO.AMLODIPINE MESYLATE MONOHIDRATE IS PREPARED EITHER FROM ANHYDRO AMLODIPINE MESILATE, OR IN THE PRESENCE OF A SOLVENT MEDIUM OF WATER IMMISCIBLE FROM PULIFIED AMLODIPINE AND SULPHONIC ACID OF METHANE.

PA20048601501A 2003-04-25 2004-04-23 PROCESS PA8601501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309471A GB0309471D0 (en) 2003-04-25 2003-04-25 Process
GB0314617A GB0314617D0 (en) 2003-06-23 2003-06-23 Process

Publications (1)

Publication Number Publication Date
PA8601501A1 true PA8601501A1 (en) 2004-12-16

Family

ID=33420880

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20048601501A PA8601501A1 (en) 2003-04-25 2004-04-23 PROCESS

Country Status (6)

Country Link
AR (1) AR044063A1 (en)
CL (1) CL2004000864A1 (en)
DE (1) DE112004000712T5 (en)
GB (1) GB2415696B (en)
PA (1) PA8601501A1 (en)
WO (1) WO2004096770A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1152013C (en) * 2001-11-22 2004-06-02 张喜田 Levo-amlodipine salt able to generate hydrate and its hydrate and preparation
WO2021114012A1 (en) * 2019-12-09 2021-06-17 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, preparation method therefor and use thereof
CN112538044B (en) * 2019-12-09 2021-08-13 昆明赛诺制药股份有限公司 Amlodipine mesylate monohydrate, and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (en) * 1982-03-11 1991-12-09 Pfizer CHANGES FOR THE PREPARATION FOR THE PREPARATION OF 2-Amino-CO-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-4-Methyl-2-D-Hydroxy
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
DE50112189D1 (en) * 2001-01-09 2007-04-26 Siegfried Generics Int Ag Salts of amlodipine mesylate

Also Published As

Publication number Publication date
GB2415696B (en) 2007-06-20
GB2415696A (en) 2006-01-04
DE112004000712T5 (en) 2006-10-19
GB0522075D0 (en) 2005-12-07
WO2004096770A1 (en) 2004-11-11
CL2004000864A1 (en) 2005-04-22
AR044063A1 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
ITMI20000155A0 (en) EQUIPMENT FOR WATER DESALINATION BY REVERSE OSMOSIS WITH ENERGY RECOVERY
MA26265A1 (en) RECOVERY OF WATER AND A BRINE CONCENTRATE FOR USE FROM DOMESTIC WASTEWATER.
NO20025795L (en) Underwater hydrocarbon production system
NO20014434L (en) Procedure for downhole separation and gas / water reinjection
GB2430455B (en) Method of treating a water, methane and other hydrocarbons containing formation
DE602004010729D1 (en) Production of improved silicon-based MEMS devices
NO20020377D0 (en) Grafted polymer as gas hydrate inhibitors
NO20053836D0 (en) Preparations containing additives for water control and formation damage control and methods for their use.
NO20035848L (en) New tissue factor-directed antibodies such as anticoagulants
DE60318035D1 (en) POLYMER MICROEMULSIONS
DE602004009828D1 (en) IMPROVED REVERSE OF POLYMERS IN INVERSE EMULSION
EA200701531A1 (en) WATER ABSORBING POLYMERS FOR TREATMENT OF MAINS AND DRILLING SOLUTIONS ON AQUEOUS BASE
DE50015505D1 (en) polymer electrolyte
DE60328001D1 (en) ELECTROCHEMICAL SURVEYING SYSTEMS
BR0310023B1 (en) Water soluble polymer dispersion, method of producing a water soluble polymer dispersion and use of a water soluble polymer dispersion.
BR0315852B1 (en) process and apparatus for continuous desalination of water by reverse osmosis.
BR0112988B1 (en) method of connecting a first floating structure to the seabed, and floating structure.
PA8601501A1 (en) PROCESS
ITRM20030489A0 (en) ENERGY PRODUCTION SYSTEM FROM THE EXPLOITATION OF CURRENTS IN FLUIDS.
DE60320728D1 (en) A method for the preparation of polymer electrolyte membranes
AR048040A1 (en) MESOTRIONA PURIFICATION METHOD
NO20032698L (en) Self-erecting rig
DE60232018D1 (en) 3-PHENYL-2-ARYLALKYLTHIOPROPIONIC ACID DERIVATIVES AS SELECTIVE AGONISTS OF PPAR-ALPHA
SE526867C8 (en) In case of emergency, automatic disconnectable fluid coupling
BRPI0416580A (en) water treatment system and method